Cargando…
Direct-acting Antiviral Agents in Hepatitis C Virus-infected Renal Allograft Recipients: Treatment and Outcome Experience from Single Center
Hepatitis C virus (HCV) infection in renal allograft recipient is associated with increased morbidity and mortality. At present, only few studies related to treatment and outcomes of HCV-infected renal allograft recipients with DAAs have been published. We aimed the study to assess the efficacy and...
Autores principales: | Prasad, N., Patel, M. R., Pandey, A., Jaiswal, A., Bhadauria, D., Kaul, A., Sharma, R. K., Mohindra, S., Pandey, G., Goel, A., Gupta, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998719/ https://www.ncbi.nlm.nih.gov/pubmed/29962673 http://dx.doi.org/10.4103/ijn.IJN_190_17 |
Ejemplares similares
-
Mucormycosis of the Thyroid Gland: A Cataclysmic Event in Renal Allograft Recipient
por: Prasad, N., et al.
Publicado: (2018) -
Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
por: Armando, Calogero, et al.
Publicado: (2019) -
Corrigendum: Direct-acting antiviral agents in Hepatitis C Virus infected renal allograft recipients: Treatment and outcome experience from single center
Publicado: (2018) -
WCN23-1139 A Study of Long-Term Outcome of Mycophenolate Dose Modulation in Renal Allograft Recipients With SARS-CoV2 Infection During COVID-19 Pandemic
por: MEYYAPPAN, J., et al.
Publicado: (2023) -
Erratum to “Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients”
por: Calogero, Armando, et al.
Publicado: (2019)